...
首页> 外文期刊>International journal of molecular medicine >Long non-coding RNA DANCR regulates the proliferation and osteogenic differentiation of human bone-derived marrow mesenchymal stem cells via the p38 MAPK pathway
【24h】

Long non-coding RNA DANCR regulates the proliferation and osteogenic differentiation of human bone-derived marrow mesenchymal stem cells via the p38 MAPK pathway

机译:长期非编码RNA DANCR通过P38 MAPK途径调节人骨源性骨髓间充质干细胞的增殖和成骨分化

获取原文
获取原文并翻译 | 示例
           

摘要

Long non-coding RNAs (lncRNAs) have been established to participate in the complex network of various biological processes and play important roles in the differentiation of mesenchymal stem cells (MSCs). However, the roles of lncRNAs in the mechanisms of the osteogenic differentiation of human bone marrow-derived MSCs (HBMSCs) are poorly understood. Thus, this study aimed to investigate the effects of the lncRNA, differentiation antagonizing non-protein coding RNA (DANCR), on the proliferation and osteogenic differentiation of HBMSCs. We found that lncRNA DANCR was abnormally decreased in HBMSCs during osteogenic differentiation. DANCR knockdown induced by transfection with siRNA targeting DANCR (si-DANCR) significantly enhanced the proliferation and osteogenic differentiation of HBMSCs. By contrast, when DANCR expression was enhanced by transfection with a DANCR overexpression vector (pcDNA-DANCR), the proliferation and osteogenic differentiation of the HBMSCs were markedly inhibited. We further found that mitogen-activated protein kinase (MAPK) pathways were involved in the DANCR-mediated proliferation and osteogenic differentiation of HBMSCs. Moreover, DANCR was found to mediate the proliferation and osteogenic differentiation of HBMSCs via p38 MAPK inactivation, but not via extracellular signal-regulated protein kinase (ERK)1/2 or c-Jun N-terminal kinase (JNK) MAPKs, but. Combination treatment (pcDNA-DANCR and with the p38 specific inhibitor, SB203580) led to synergistic inhibitory effects, and these inhibitory effects were reversed by DANCR knockdown. These findings not only provide a novel interpretation for the mechanisms of the proliferation and osteogenic differentiation of HBMSCs, but also suggest that DANCR may be a novel therapeutic target for bone-destructive diseases in the future.
机译:已经建立了长期非编码RNA(LNCRNA)参与各种生物过程的复杂网络,并在间充质干细胞(MSCs)的分化中起重要作用。然而,LNCRNA在人骨髓衍生的MSCs(HBMSCs)的骨质发生分化机制中的作用较差。因此,本研究旨在研究LNCRNA,分化拮抗非蛋白质编码RNA(DANCR)对HBMSCs的增殖和成骨分化的影响。我们发现在成骨分化期间HBMSCs在HBMSC中异常降低LNCRNA DANCR。通过用siRNA转染靶向DANCR(SI-DANCR)诱导的DANCR敲低显着提高了HBMSC的增殖和骨质发生分化。相比之下,当通过用丹麦过表达载体(PCDNA-DANCR)转染而增强了DANCR表达时,HBMSCs的增殖和骨质发生分化明显抑制。我们进一步发现,丝裂原激活的蛋白激酶(MAPK)途径参与了丹麦克介导的HBMSC的增殖和骨质发生分化。此外,发现DANCR通过P38 MAPK灭活介导HBMSCs的增殖和成骨分化,但不通过细胞外信号调节蛋白激酶(ERK)1/2或C-JUM N-末端激酶(JNK)MAPKS,但是。组合治疗(PCDNA-DANCR和P38特异性抑制剂,SB203580)导致协同抑制作用,丹麦克敲低逆转这些抑制作用。这些发现不仅为HBMSC的增殖和骨质发生分化机制提供了一种新颖的解释,而且表明DANCR可能是未来骨破坏性疾病的新疗法靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号